Canadian regulators approve Covidien's imaging agent

07/6/2009 | American City Business Journals

Health Canada has approved Covidien's abbreviated new drug submission for its kit used in preparing Technetium Tc 99m Sestamibi Injection, a generic version of Dupont's Cardiolite. With the approval, Covidien said it could have the myocardial perfusion imaging agent on the Canadian market this summer.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD